These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3103386

  • 1. Pathology of MPTP in the marmoset.
    Gibb WR, Lees AJ, Wells FR, Barnard RO, Jenner P, Marsden CD.
    Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
    [No Abstract] [Full Text] [Related]

  • 2. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
    Jenner P, Rose S, Nomoto M, Marsden CD.
    Adv Neurol; 1987; 45():183-6. PubMed ID: 2881443
    [No Abstract] [Full Text] [Related]

  • 3. The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Gibb WR, Terruli M, Lees AJ, Jenner P, Marsden CD.
    Mov Disord; 1989; 4(1):53-74. PubMed ID: 2494438
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The neurotoxic effect of MPTP and its mechanisms].
    Xu XJ.
    Sheng Li Ke Xue Jin Zhan; 1988 Oct; 19(4):310-4. PubMed ID: 3074503
    [No Abstract] [Full Text] [Related]

  • 6. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS, Markey SP, Phillips JM, Chiueh CC.
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [Abstract] [Full Text] [Related]

  • 7. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Waters CM, Hunt SP, Jenner P, Marsden CD.
    Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of recovery in MPTP-induced parkinsonism.
    Sandyk R.
    Neuroscience; 1988 Nov; 27(2):727-9. PubMed ID: 3146035
    [No Abstract] [Full Text] [Related]

  • 9. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 10. Effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/MPTP/on mouse substantia nigra in vitro. Fluorescence and electron microscopic examination.
    Renkawek K.
    Prog Clin Biol Res; 1987 Apr; 253():255-63. PubMed ID: 3501590
    [No Abstract] [Full Text] [Related]

  • 11. Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.
    Doudet D, Gross C, Lebrun-Grandie P, Bioulac B.
    Electromyogr Clin Neurophysiol; 1986 Dec; 26(8):711-27. PubMed ID: 3493894
    [No Abstract] [Full Text] [Related]

  • 12. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW.
    Adv Neurol; 1993 Dec; 60():34-9. PubMed ID: 8420148
    [No Abstract] [Full Text] [Related]

  • 13. Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP.
    Chen SD, Xu DL, Yu HZ, Tang QM, Xu XR, Wang ZG, Liang PF.
    Chin Med J (Engl); 1988 Dec; 101(12):879-83. PubMed ID: 3150735
    [No Abstract] [Full Text] [Related]

  • 14. Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.
    Chiueh CC, Markey SP, Burns RS, Johannessen JN, Jacobowitz DM, Kopin IJ.
    Psychopharmacol Bull; 1984 Dec; 20(3):548-53. PubMed ID: 6332333
    [No Abstract] [Full Text] [Related]

  • 15. Chronic administration of MPTP to marmosets.
    Albanese A, Altavista MC, Gozzo S, Rossi P, Colosimo C, Bentivoglio AR, Perretta G, Elia M, Monaco V, Macchi G.
    Adv Neurol; 1990 Dec; 53():239-44. PubMed ID: 1978517
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinsonism and MPTP (methylphenyltetrahydropyridine)].
    Nagatsu T.
    No To Shinkei; 1986 Jul; 38(7):706-7. PubMed ID: 3489476
    [No Abstract] [Full Text] [Related]

  • 17. Endogenous analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: indoleamine derived tetrahydro-beta-carbolines as potential causative factors in Parkinson's disease.
    Collins MA, Neafsey EJ, Cheng BY, Hurley-Gius K, Ung-Chhun NA, Pronger DA, Christensen MA, Hurley-Gius D.
    Adv Neurol; 1987 Jul; 45():179-82. PubMed ID: 3493625
    [No Abstract] [Full Text] [Related]

  • 18. MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity.
    Bocchetta A, Piccardi MP, Zuddas A, Bernardi F, Zompo MD, Corsini GU.
    Funct Neurol; 1988 Jul; 3(4):439-47. PubMed ID: 3072279
    [No Abstract] [Full Text] [Related]

  • 19. MPTP: current concepts and controversies.
    Langston JW, Irwin I.
    Clin Neuropharmacol; 1986 Jul; 9(6):485-507. PubMed ID: 3542203
    [No Abstract] [Full Text] [Related]

  • 20. [MPTP and Parkinson's disease].
    Imai H.
    No To Shinkei; 1988 Nov; 40(11):1011-24. PubMed ID: 3064783
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.